Ratings by KeyBanc (Paul Knight)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/1/2024 | Castle Biosciences | CSTL | Maintain | Overweight (N/A) |
|
Details | ||
| 2/15/2024 | Repligen | RGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 2/13/2024 | West Pharmaceutical | WST | Maintain | Overweight (N/A) |
|
Details | ||
| 2/2/2024 | Revvity Inc | RVTY | Maintain | Overweight (N/A) |
|
Details | ||
| 12/8/2023 | Avid Bioservices | CDMO | Maintain | Overweight (N/A) |
|
Details | ||
| 11/1/2023 | Bio-Techne Corp. | TECH | Maintain | Overweight (N/A) |
|
Details | ||
| 11/1/2023 | Repligen | RGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 10/31/2023 | Revvity Inc | RVTY | Maintain | Overweight (N/A) |
|
Details | ||
| 10/26/2023 | Thermo Fisher Scientific | TMO | Downgrade | Sector Weight (Overweight) |
458.26 (571.73) |
24.76% | Details | |
| 9/27/2023 | Danaher | DHR | Maintain | Overweight (N/A) |
|
Details | ||
| 8/30/2023 | West Pharmaceutical | WST | Maintain | Overweight (N/A) |
|
Details | ||
| 8/30/2023 | Stevanato Group S.p.A. | STVN | Maintain | Overweight (N/A) |
|
Details | ||
| 8/21/2023 | West Pharmaceutical | WST | Maintain | Overweight (N/A) |
|
Details | ||
| 8/11/2023 | Translate Bio | TBIO | Downgrade | Sector Weight (Overweight) |
1.35 (0.32) |
-76.3% | Details | |
| 8/8/2023 | Maravai LifeScience Holdings Inc. | MRVI | Downgrade | Sector Weight (Overweight) |
11.50 (7.58) |
-34.09% | Details | |
| 7/17/2023 | CryoPort | CYRX | Downgrade | Sector Weight (Overweight) |
14.60 (16.03) |
9.79% | Details | |
| 7/12/2023 | Standard BioTools Inc | LAB | New Coverage | Overweight (N/A) |
2.22 (2.36) |
6.31% | Details | |
| 7/12/2023 | Alpha Teknova Inc. | TKNO | New Coverage | Sector Weight (N/A) |
2.68 (1.70) |
-36.57% | Details | |
| 5/24/2023 | Thermo Fisher Scientific | TMO | Maintain | Overweight (N/A) |
|
Details | ||
| 5/24/2023 | Agilent | A | Downgrade | Sector Weight (Overweight) |
129.09 (136.37) |
5.64% | Details | |
| 5/10/2023 | Azenta, Inc. | AZTA | Downgrade | Sector Weight (Overweight) |
45.43 (51.50) |
13.36% | Details | |
| 5/5/2023 | Castle Biosciences | CSTL | Maintain | Overweight (N/A) |
|
Details | ||
| 3/14/2023 | Avid Bioservices | CDMO | Upgrade | Overweight (Sector Weight) |
13.95 (7.32) |
-47.53% | Details | |
| 2/23/2023 | Maravai LifeScience Holdings Inc. | MRVI | Maintain | Overweight (N/A) |
|
Details | ||
| 12/8/2022 | CryoPort | CYRX | Maintain | Overweight (N/A) |
|
Details | ||
| 12/2/2022 | West Pharmaceutical | WST | Maintain | Overweight (N/A) |
|
Details | ||
| 11/22/2022 | Agilent | A | Maintain | Overweight (N/A) |
|
Details | ||
| 8/5/2022 | Exagen | XGN | Downgrade | Sector Weight (Overweight) |
8.30 (1.41) |
-83.01% | Details | |
| 8/5/2022 | Harvard Bioscience Inc. | HBIO | Maintain | Overweight (N/A) |
|
Details | ||
| 6/2/2022 | Agilent | A | Maintain | Overweight (N/A) |
|
Details | ||
| 5/10/2022 | Stevanato Group S.p.A. | STVN | Maintain | Overweight (N/A) |
|
Details | ||
| 5/5/2022 | Bio-Techne Corp. | TECH | Maintain | Overweight (N/A) |
|
Details | ||
| 3/28/2022 | Codex DNA Inc. | DNAY | Maintain | Overweight (N/A) |
|
Details | ||
| 3/14/2022 | OncoCyte Corp | OCX | Downgrade | Sector Weight (Overweight) |
1.40 (2.44) |
74.29% | Details | |
| 3/9/2022 | Stevanato Group S.p.A. | STVN | Maintain | Overweight (N/A) |
|
Details | ||
| 12/8/2021 | Avid Bioservices | CDMO | Downgrade | Sector Weight (Overweight) |
28.18 (7.32) |
-74.02% | Details | |
| 11/17/2021 | Brooks Automation Inc. | BRKS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/11/2021 | Exagen | XGN | Maintain | Overweight (N/A) |
|
Details | ||
| 9/17/2021 | Repligen | RGEN | Maintain | Overweight (N/A) |
|
Details | ||
| 9/15/2021 | Bio-Techne Corp. | TECH | Upgrade | Overweight (Sector Weight) |
509.89 (62.66) |
-87.71% | Details | |
| 9/8/2021 | Avantor Inc. | AVTR | Maintain | Overweight (N/A) |
|
Details | ||
| 8/10/2021 | Stevanato Group S.p.A. | STVN | New Coverage | Overweight (N/A) |
20.62 (27.52) |
33.46% | Details | |
| 7/29/2021 | West Pharmaceutical | WST | Maintain | Overweight (N/A) |
|
Details | ||
| 7/13/2021 | Codex DNA Inc. | DNAY | New Coverage | Overweight (N/A) |
17.33 (1.30) |
-92.5% | Details | |
| 7/12/2021 | Thermo Fisher Scientific | TMO | Maintain | Overweight (N/A) |
|
Details | ||
| 7/12/2021 | Agilent | A | Maintain | Overweight (N/A) |
|
Details | ||
| 6/30/2021 | Avid Bioservices | CDMO | Maintain | Overweight (N/A) |
|
Details | ||
| 6/28/2021 | Berkeley Lights | BLI | Downgrade | Sector Weight (Overweight) |
48.10 (1.20) |
-97.51% | Details | |
| 5/26/2021 | Agilent | A | Maintain | Overweight (N/A) |
|
Details | ||
| 5/6/2021 | Harvard Bioscience Inc. | HBIO | Maintain | Overweight (N/A) |
|
Details | ||
| 3/18/2021 | Thermo Fisher Scientific | TMO | Upgrade | Overweight (Sector Weight) |
442.61 (571.73) |
29.17% | Details | |
| 2/17/2021 | Agilent | A | Maintain | Overweight (N/A) |
|
Details |
